• Home
• Services
• One-Stop Microfluidic Solutions
• Organ-On-A-Chip Solution
• CBLMF™ 3D Tissue and Organ-On-A-Chip Model Development Services
• Eye-Organ-On-A-Chip Model

Creative Biolabs' Eye-On-A-Chip Development Service delivers custom-engineered, biologically precise in vitro platforms that replicate diverse ocular structures. This solution empowers researchers to investigate ophthalmic diseases, assess drug performance and safety parameters, and uncover foundational mechanisms of ocular function

Contact our team to get an inquiry now!

Background

The visual system comprises a sophisticated network of ocular components working synergistically to enable sight. At the anterior segment, the cornea—a transparent dome—performs primary light refraction, directing photons toward the adjustable lens that perfects focal alignment onto the photosensitive posterior layer. This retinal matrix contains stratified neuronal networks where rod and cone photoreceptors transduce luminous stimuli into neural codes. Processed electrochemical signals then propagate through the optic pathway to visual cortices. Integral to retinal homeostasis, the blood-retinal barrier selectively governs molecular trafficking, blocking bloodborne pathogens while permitting controlled metabolite exchange.

Fig 1. Human eye. Distributed under CC BY-SA 3.0, from Wiki, without modification.

Established research paradigms for eye-related pathologies have primarily depended on two-dimensional (2D) culture systems and animal-derived experimentation. Although 2D cellular arrays enable foundational biological observations, their deficient spatial organization, and cell signaling networks inadequately reproduce human ocular microenvironments—notably failing to simulate the intraocular pressure dynamics critical in glaucoma or the layered neuronal structures required for light signal processing. Despite their utility in mechanistic studies, cross-species models exhibit reduced clinical predictive power stemming from evolutionary physiological disparities, particularly in ocular biomechanics and disease manifestation. These collective limitations drive urgent demand for human tissue-mimetic systems that authentically reproduce ocular cellular architecture with high physiological accuracy.

Eye-on-a-chip

Traditional research methodologies for eye-related disorders have primarily relied on two-dimensional (2D) culture systems and animal-derived models. Although 2D cellular arrays provide fundamental biological data, their lack of three-dimensional organization and cell-cell communication networks prevents accurate simulation of ocular environments—especially the fluid drainage mechanics critical in glaucoma or the layered cellular organization needed for light signal conversion. While animal experimentation aids mechanistic understanding, their clinical relevance is limited by physiological differences between species, particularly in eye structure and disease mechanisms. These cumulative limitations highlight the urgent need for advanced tissue-engineered systems that accurately mimic human ocular biology.

• Corneal Organ-on-a-Chips

The cornea's layered architecture includes five distinct laminae: the epithelium, Bowman's layer, stroma, Descemet's membrane, and endothelium. Apical epithelial tight junctions create rate-limiting barriers for topical pharmacological penetration. The stroma's collagenous framework hinders lipophilic agent diffusion, complemented by endothelial barriers regulating molecule transit. Endogenous xenobiotic-processing machinery within corneal tissues governs medicinal bioavailability through enzymatic metabolism and transporter activity. Conventional cell passaging techniques often attenuate these native properties, highlighting the need for 3D primary cellular constructs that recapitulate corneal histophysiology.

Fig 2. Corneal organ-on-a-chip platforms and their translational application.^1,3

Scientists pioneered a cornea-on-a-chip system, revolutionizing ocular surface modeling. Their design replicated human ocular anatomy via a curved polystyrene substrate interfaced with perfusion channels, lacrimal ducts, and a hydrogel-based mechanoactive eyelid mimicking blink cycles. Construction involved layering PDMS elastomers onto a lithographically molded polystyrene scaffold coated with ECM hydrogels to promote corneal cell adhesion. A programmable fluidic system regulated medium flow, while the eyelid's electromechanical actuators reproduced natural blinking. This model introduced an air-liquid interface (ALI) to parallel in vivo conditions: basal scaffold perfusion sustained nutrient exchange, while apical epithelial cells faced air exposure.

• Retinal Organ-on-a-Chip

The retina, a stratified neurosensory tissue lining the ocular posterior, transduces photic stimuli into electrochemical signals for central visual processing. Its laminar architecture features light-sensitive neurons—rods (scotopic vision) and cones (photopic acuity)—occupying the outermost stratum. These photoreceptors exhibit polarized morphology: light-capturing outer segments and metabolically active inner compartments. Adjacent lies the retinal pigment epithelium (RPE), a monolayer critical for phagocytosing shed photoreceptor components and recycling visual cycle molecules.

Fig 3. Retinal organ-on-a-chip platforms and their translational application.^1,3

Contrasting the avascular cornea, retinal tissue requires extensive microvasculature to sustain its intense metabolic demands. Vascularized microfluidic circuits in retinal microphysiological systems (MPS) better emulate this capillary network than static organoid cultures. Pioneering work by Chen et al. engineered a transmembrane retinal MPS platform co-culturing RPE and endothelial cells on a microporous PDMS interface within perfusion chambers.^2,3 The biomimetic Bruch's membrane analogue involved fibronectin-coated micropillar arrays fabricated via spin-coating. Hypoxia simulation through CoCl2 exposure elevated VEGF paracrine signaling, replicating pathologic neurovascular crosstalk. Barrier integrity validation employed ZO-1 immunostaining and molecular flux assays. While enabling polarized cell interactions, such 2D membrane systems inadequately model 3D angiogenic processes, prompting the development of micropillar-based trilayered vascular constructs.

Applications

Eye-on-a-chip models have a wide range of applications in:

• Disease Modeling: Replicating ocular diseases such as age-related macular degeneration (AMD), glaucoma, and corneal dystrophies to study their pathogenesis and identify potential therapeutic targets.
• Drug Discovery: Screening and evaluating the efficacy and toxicity of new drug candidates for ocular diseases.
• Personalized Medicine: Developing patient-specific models to predict individual responses to therapies.
• Basic Research: Investigating fundamental aspects of eye biology, such as cell-cell interactions, tissue development, and the effects of environmental factors.
• Toxicity Testing: Assessing the safety of ophthalmic drugs and other compounds on ocular tissues.

Experience the Creative Biolabs Advantage - Get a Quote Today

Why Choose Us?

Creative Biolabs offers a unique combination of expertise, technology, and customer focus in Eye-On-A-Chip model development. Our commitment to quality and innovation ensures that our clients receive the most advanced and reliable solutions for their research needs.

• Expertise: Creative Biolabs team comprises experienced scientists with extensive knowledge in microfluidics, cell biology, and ocular tissue engineering.
• Customization: We offer highly customizable solutions tailored to the specific needs of each client's research project.
• Advanced Technology: Creative Biolabs utilizes state-of-the-art microfabrication techniques and advanced cell culture methods to create physiologically relevant Eye-On-A-Chip models. As the Frontiers in Pharmacology article details, microfluidic devices offer a superior platform for creating 3D tissue models compared to traditional 2D cultures.
• Quality and Reliability: We adhere to rigorous quality control standards to ensure the reproducibility and reliability of our models.
• Collaboration: We work closely with our clients throughout the project, providing ongoing support and communication.

FAQs

Recommended Products

For researchers facing challenges in initiating microfluidic cellular investigations de novo, Creative Biolabs' engineered cell-culture systems deliver integrated solutions that streamline workflow bottlenecks.

Our chips offer the freedom to choose the cell seeding channels and perfusion conditions, enabling various cell culture modes.

For more information about Creative Biolabs products and services, please contact us.

References

1. Lu, Renhao. "Advances in Ophthalmic Organ-on-a-Chip Models: Bridging Translational Gaps in Disease Modeling and Drug Screening." International Journal of Translational Medicine 4.4 (2024): 710-725.
2. Chen, Li-Jiun, et al. "Microfluidic co-cultures of retinal pigment epithelial cells and vascular endothelial cells to investigate choroidal angiogenesis." Scientific Reports 7.1 (2017): 3538.
3. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only. Not For Clinical Use.